Nanobiotix S.A. Operating Expense
Nanobiotix S.A. (NBTX) reported Operating Expense of EUR 43.41 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-31.
Financial Statements › Expense Statement › Operating Expenses
ifrs-full:OperatingExpense · last filed 2026-03-31
| Period end | Operating Expense 6 month | Operating Expense 12 month |
|---|---|---|
| 2025-12-31 | 43.41M EUR 20-F · filed 2026-03-31 | |
| 2025-06-30 | 25.83M EUR 6-K · filed 2025-09-30 | |
| 2024-12-31 | 61.20M EUR 20-F · filed 2026-03-31 | |
| 2024-06-30 | 32.94M EUR 6-K · filed 2025-09-30 | |
| 2023-12-31 | 62.99M EUR 20-F · filed 2026-03-31 | |
| 2023-06-30 | 28.66M EUR 6-K · filed 2024-09-18 | |
| 2022-12-31 | 51.48M EUR 20-F · filed 2025-04-02 | |
| 2022-06-30 | 27.21M EUR 6-K · filed 2023-09-26 | |
| 2021-12-31 | 55.23M EUR 20-F · filed 2024-04-24 | |
| 2021-06-30 | 31.10M EUR 6-K · filed 2022-09-28 | |
| 2020-12-31 | 38.94M EUR 20-F · filed 2023-04-24 | |
| 2020-06-30 | 19.83M EUR 6-K · filed 2021-09-08 | |
| 2019-12-31 | 49.32M EUR 20-F · filed 2022-04-08 | |
| 2018-12-31 | 33.55M EUR 20-F/A · filed 2021-04-08 |